News | Computed Tomography (CT) | November 08, 2022

Cardio StillShot enables 6x higher temporal resolution compared to conventional image reconstruction methods by detecting and correcting motion in the heart 

Cardio StillShot enables 6x higher temporal resolution compared to conventional image reconstruction methods by detecting and correcting motion in the heart

November 8, 2022 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announced the U.S. launch of the Scenaria View Focus Edition Computed Tomography (CT) system, a premium scanner with an advanced Cardiac Motion Correction feature, called Cardio StillShot. The system is designed for routine and advanced clinical applications, including coronary computed tomography angiography (CCTA), interventional CT, extended coverage shuttle scanning for perfusion exams, and dual energy examinations. The system will be showcased for the first time at the 2022 Radiological Society of North America (RSNA) annual meeting held November 27 – December 1 at McCormick Place in Chicago. 

Like every person is different, so is every heart. The rhythm of the heart affects CT image quality and the rhythm of workflow. At heart rates of 60-75 beats per minute (BPM), there is adequate time to take images between heartbeats. However, when heart rates rise above 75 BPM, the imaging time window becomes too short and can cause non-diagnostic images. Dependable detailed imaging of the coronary arteries requires high temporal resolution. 

Fujifilm’s Cardio StillShot feature helps clinicians capture clear images of the heart - even on the most challenging heart rhythms by simultaneously acquiring two data sets in the scan. These data sets are then compared against each other to detect and correct motion. The final images have an effective temporal resolution of just 28 milliseconds, compared to 175 milliseconds without Cardio StillShot. 

“Providers need a powerful CT system that gives them the diagnostic confidence to make the right treatment decisions for their patients,” said Mark Silverman, director of marketing for CT, Fujifilm Healthcare Americas Corporation. “Fujifilm’s Scenaria View Focus Edition makes this possible through the convergence of high temporal resolution, enhanced workflow that reduce examination time, and advanced dose reduction capabilities.” 

Fujifilm received FDA clearance for the Scenaria View Focus Edition in April 2022. For more information: https://healthcaresolutions-us.fujifilm.com/mrict/scenaria-view 


Find more RSNA22 coverage here  


Related Content

News | Digital Pathology

March 29, 2026 — Leica Microsystems has introduced the Viventis SCAPE light sheet microscope. Viventis SCAPE enables ...

Time April 01, 2026
arrow
News | Radiology Business

March 31, 2026 — Radon Medical Imaging, a medical imaging equipment maintenance and repair services company, has has ...

Time March 31, 2026
arrow
News | Radiology Imaging

March 26, 2026 — GE HealthCare has announced a renewed research collaboration with Stanford Medicine Department of ...

Time March 30, 2026
arrow
News | Cardiac Imaging

March 28, 2026 — When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn't think it ...

Time March 30, 2026
arrow
News | Digital Pathology

March 11, 2026 — Royal Philips has announced the expansion of its digital pathology portfolio with new cloud-enabled ...

Time March 26, 2026
arrow
News | FDA

March 24, 2026 — MARS Bioimaging, a New Zealand–headquartered medical device company, has received U.S. Food and Drug ...

Time March 25, 2026
arrow
News | Radiology Imaging

March 23, 2026 — Samsung Medison hsa announced that its U.S. medical imaging businesses, previously operating as ...

Time March 23, 2026
arrow
News | Radiology Business

March 1, 2026 — A new study from the Harvey L. Neiman Health Policy Institute found that practice turnover (i.e ...

Time March 19, 2026
arrow
News | Radiology Education

March 17, 2026 – The Center for Radiology Education (CRE) has announced a nationwide initiative to provide scholarships* ...

Time March 17, 2026
arrow
News | Breast Imaging

March 10, 2026 — QT Imaging Holdings has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an ...

Time March 13, 2026
arrow
Subscribe Now